Edgewise Therapeutics Inc. Common Stock vs Envista Holdings Corporation Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.11 (market cap $3.94B), while Envista Holdings Corporation Common Stock trades at $22.45 (market cap $3.64B). The key difference: Edgewise Therapeutics Inc. Common Stock and Envista Holdings Corporation Common Stock are close in size by market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Envista Holdings Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Envista Holdings Corporation Common Stock for 0 Days on average.
| EWTX | NVST | |
|---|---|---|
Market Cap | $3.94B | $3.64B |
Volume | 810,104 | 2,411,697 |
Sector | Health | Health |
52-Week High | $48.35 | $30.26 |
52-Week Low | $14.89 | $18.95 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.48B | $4.10B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Envista Holdings Corporation is a global dental products company that develops, manufactures, and markets dental implants, orthodontic systems, and other consumables and equipment for dental professionals worldwide.
Read more on NVST →